SEC Form 4 insider trading filings tracked in real time from EDGAR

Silver Andrew Jacob — Chief Financial Officer

Insider trading activity for Silver Andrew Jacob sourced from SEC EDGAR Form 4 filings.

Overview

  • Title: Chief Financial Officer
  • Company: CRISPR Therapeutics AG
  • Total insider trades: 1
  • Total buy volume: $0
  • Total sell volume: $0
  • Last trade: Oct 21, 2026

Recent Trades

DateInsiderTicker / Company TypeSharesValue
Oct 19, 2026 Silver Andrew Jacob CRSP CRISPR Therapeutics AG OTHER 25,000 $0

← All executives · Full trades feed